Shares of UDG Healthcare plc (LON:UDG) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and six have issued a hold rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is GBX 825.71 ($10.86).
UDG has been the topic of a number of recent research reports. Peel Hunt restated an “add” rating and set a GBX 840 ($11.05) price target on shares of UDG Healthcare in a research note on Thursday, August 10th. Liberum Capital restated a “buy” rating and set a GBX 930 ($12.23) price target on shares of UDG Healthcare in a research note on Thursday, August 3rd. N+1 Singer restated a “hold” rating on shares of UDG Healthcare in a research note on Thursday, August 3rd. Jefferies Group LLC upped their price target on shares of UDG Healthcare from GBX 830 ($10.92) to GBX 855 ($11.25) and gave the company a “hold” rating in a research note on Wednesday, October 4th. Finally, Numis Securities Ltd restated a “hold” rating and set a GBX 765 ($10.06) price target on shares of UDG Healthcare in a research note on Monday, August 14th.
Shares of UDG Healthcare (LON:UDG) traded down GBX 1.50 ($0.02) during mid-day trading on Monday, hitting GBX 861 ($11.32). 403,324 shares of the company were exchanged, compared to its average volume of 592,426. UDG Healthcare has a 12 month low of GBX 612 ($8.05) and a 12 month high of GBX 963 ($12.67).
WARNING: This piece of content was first posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://transcriptdaily.com/2017/11/27/udg-healthcare-plc-udg-given-consensus-recommendation-of-hold-by-brokerages.html.
UDG Healthcare Company Profile
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.